Aharon Gal
Chief Strategy & Growth OfficerNovartis
PharmaceuticalsView Profile →Executive Vice President, General Medicines · Sanofi
Thomas Grenier is Sanofi’s executive vice president for General Medicines, following work in consulting, supply chain, commercial management and North American vaccines.
Last reviewed: Nov 15, 2026
Thomas Grenier is Sanofi’s executive vice president for General Medicines, following work in consulting, supply chain, commercial management and North American vaccines.
Grenier worked at McKinsey before joining Sanofi in 2013. His subsequent assignments have covered global supply chain, field sales and account management, in-country marketing, and global franchise and product strategy.
He spent several years working in the United States, most recently as head of North America Vaccines. These roles combined responsibility for product and commercial strategy with experience in the practical delivery and sale of medicines and vaccines.
In September 2026, Grenier became executive vice president for General Medicines. The business encompasses diabetes, cardiovascular medicine, transplantation and established products. His appointment brought an executive with operational, commercial and vaccine-business experience into leadership of this broader medicines portfolio.
Grenier holds a management degree specializing in finance from HEC Paris and an MBA from Harvard University. Outside his pharmaceutical work, he is an experienced mountaineer, rock climber and trail runner.
Grenier earned an MSc in management, specializing in finance, at HEC Paris and an MBA at Harvard University.